Promising Concepts in Subarachnoid Hemorrhage

  • A. M. Naidech


Management strategies for subarachnoid hemorrhage (SAH) include early aneurysm obliteration, pharmacologic prevention of vasospasm, therapeutic (but not prophylactic) hyperdynamic therapy, targeted critical care, and rehabilitation. Despite recent advances, major gaps in our knowledge remain, and many potentially salvageable patients have devastating outcomes. Neuroprotective, prognostic, and pharmacologic developments are especially promising. This chapter highlights areas of intensive study in SAH management, with hopes that the efforts of dedicated clinician-scientists will come to fruition in the near future. I mean to highlight promising areas of active study with preliminary data or research funding, not today’s state-of-the-art. There are no express or implied guarantees about actual progress.


Acute Ischemic Stroke Intracranial Aneurysm Cerebral Vasospasm Unruptured Aneurysm Symptomatic Vasospasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wiebers DO for the ISUIA Investigators (2003) Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362:103–110CrossRefPubMedGoogle Scholar
  2. 2.
    The Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study Group (1999) Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage. N Engl J Med 341:1344–1350CrossRefGoogle Scholar
  3. 3.
    Juvela S, Porras M, Poussa K (2000) Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg 93:379–387PubMedCrossRefGoogle Scholar
  4. 4.
    Meng H, Feng Y, Woodward SH, et al (2005) Mathematical model of the rupture mechanism of intracranial saccular aneurysms through daughter aneurysm formation and growth. Neurol Res 27:459–465CrossRefPubMedGoogle Scholar
  5. 5.
    Burleson AC, Strother CM, Turitto VT (1995) Computer modeling of intracranial saccular and lateral aneurysms for the study of their hemodynamics. Neurosurgery 37:774–782CrossRefPubMedGoogle Scholar
  6. 6.
    Jayaraman T, Berenstein V, Li X, et al (2005) Tumor necrosis factor [alpha] is a key modulator of inflammation in cerebral aneurysms. Neurosurgery 57:558–564CrossRefPubMedGoogle Scholar
  7. 7.
    Sehba FA, Mostafa G, Knopman J, Friedrich V Jr, Bederson JB (2004) Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 101:633–640PubMedGoogle Scholar
  8. 8.
    McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT (2002) Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 51:1128–1135CrossRefPubMedGoogle Scholar
  9. 9.
    Naidech AM, Janjua N, Kreiter KT, et al (2005) Predictors and impact of rebleeding after subarachnoid hemorrhage. Arch Neurol 62:410–416CrossRefPubMedGoogle Scholar
  10. 10.
    Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE (2002) Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 97:771–778PubMedGoogle Scholar
  11. 11.
    Mori T, Nagata K, Town T, Tan J, Matsui T, Asano T (2001) Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 32:636–642PubMedGoogle Scholar
  12. 12.
    McGirt MJ, Parra A, Sheng H, et al (2002) Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 33:2317–2323CrossRefPubMedGoogle Scholar
  13. 13.
    Shin HK, Lee JH, Kim CD, Kim YK, Hong JY, Hong KW (2003) Prevention of impairment of cerebral blood flow autoregulation during acute stage of subarachnoid hemorrhage by gene transfer of Cu/Zn SOD-1 to cerebral vessels. J Cereb Blood Flow Metab 23:111–120CrossRefPubMedGoogle Scholar
  14. 14.
    Yamaguchi M, Zhou C, Heistad DD, Watanabe Y, Zhang JH (2004) Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 35:2512–2517CrossRefPubMedGoogle Scholar
  15. 15.
    Ignarro L (1990) Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535–560CrossRefPubMedGoogle Scholar
  16. 16.
    Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM (2004) Association between cerebrospinal fluid levels of asymmetric dime-thyl-1-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 101:836–842PubMedGoogle Scholar
  17. 17.
    Lauer T, Preik M, Rassaf T, et al (2001) Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci U S A 98:12814–12819CrossRefPubMedGoogle Scholar
  18. 18.
    Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH (2005) Nitrite Infusions to Prevent Delayed Cerebral Vasospasm in a Primate Model of Subarachnoid Hemorrhage. JAMA 293: 1477–1484CrossRefPubMedGoogle Scholar
  19. 19.
    Diomedi M, Sallustio F, Rizzato B, et al (2005) Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study. Neurology 65:919–921CrossRefPubMedGoogle Scholar
  20. 20.
    Hutter R, Sauter BV, Reis ED, et al (2003) Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation 107:1658–1653CrossRefPubMedGoogle Scholar
  21. 21.
    Ribourtout E, Raymond J (2004) Gene therapy and endovascular treatment of intracranial aneurysms. Stroke 35:786–793CrossRefPubMedGoogle Scholar
  22. 22.
    The SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256.CrossRefGoogle Scholar
  23. 23.
    Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD (2006) The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke—II: neurologic outcome and efficacy analysis. Stroke 37:2107–2114CrossRefPubMedGoogle Scholar
  24. 24.
    Suarez JI, Shannon L, Zaidat OO, et al (2004) Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg 100:585–590PubMedGoogle Scholar
  25. 25.
    Suarez JI (2006) Treatment of subarachnoid hemorrhage with human albumin. Available at:, trial number NCT00283400, accessed 15 September 2006.
  26. 26.
    Lees KR, Zivin JA, Ashwood T, et al (2006) NXY-509 for acute ischemic stroke. N Engl J Med 354:588–600CrossRefPubMedGoogle Scholar
  27. 27.
    Asano T, Takakura K, Sano K, et al (1996) Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial. J Neurosurg 84:792–803PubMedGoogle Scholar
  28. 28.
    Giller CA, Wills MJ, Giller AM, Samson D (1998) Distribution of hematocrit values after aneurysmal subarachnoid hemorrhage. J Neuroimaging 8:169–170PubMedGoogle Scholar
  29. 29.
    Wartenberg KE, Schmidt MJ, Claassen J, et al (2006) Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 34:617–623CrossRefPubMedGoogle Scholar
  30. 30.
    Smith MJ, Le Roux PD, Elliott JP, Winn HR (2004) Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 101:1–7PubMedGoogle Scholar
  31. 31.
    Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ (2006) Higher hemoglobin is associated with less cerebral infarction, poor outcome and death after subarachnoid hemorrhage. Neurosurgery 59:775–780CrossRefPubMedGoogle Scholar
  32. 32.
    Naidech AM (2006) Prospective, randomized trial of goal hemoglobin after SAH. Available at:, accessed 15 September 2006.
  33. 33.
    Corwin HL, Gettinger A, Rodriguez RM, et al (1999) Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 27:2346–2350CrossRefPubMedGoogle Scholar
  34. 34.
    Springborg JB, Ma X, Rochat P, et al (2002) A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 135:823–839CrossRefPubMedGoogle Scholar
  35. 35.
    Kirkpatrick P (2006) Erythropoietin therapy for subarachnoid hemorrhage. Available at:, number NCT00140010. Accessed November 2006
  36. 36.
    Sehba FA, Mostafa G, Friedrich V Jr, Bederson JB (2005) Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg 102:1094–1100PubMedGoogle Scholar
  37. 37.
    Hirashima Y, Hamada H, Kurimoto M, Origasa H, Endo S (2005) Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 102:882–887PubMedGoogle Scholar
  38. 38.
    Hop JW, Rinkel GJ, Algra A, Berkelbach van der Sprenkel JW, van Gijn J (2000) Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 54:872–878PubMedGoogle Scholar
  39. 39.
    Claassen J, Peery S, Kreiter KT, et al (2003) Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 60:208–214CrossRefPubMedGoogle Scholar
  40. 40.
    Naidech AM, Kreiter KT, Janjua N, et al (2005) Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36:583–587CrossRefPubMedGoogle Scholar
  41. 41.
    Lanterna LA, Rigoldi M, Tredici G, et al (2005) APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage. Neurology 64:1238–1244PubMedGoogle Scholar
  42. 42.
    Ruigrok YM, Slooter AJ, Bardoel A, Frijns CJ, Rinkel GJ, Wijmenga C (2005) Genes and outcome after aneurysmal subarachnoid haemorrhage. J Neurol 252:417–422CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2007

Authors and Affiliations

  • A. M. Naidech
    • 1
  1. 1.Department of Anesthesiology & Critical CareNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations